NCT05865678 2024-02-21
SKETCh
The Christie NHS Foundation Trust
Unknown
Clinical Trials
91 trialsNCT04504526 2023-09-15
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT02825836 2023-07-13
Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects
Telios Pharma, Inc.
Phase 1/2 Unknown
NCT05932173 2023-07-11
A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Phase 1/2 Unknown
NCT05576532 2023-06-28
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT04271410 2023-04-18
CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
Chongqing Precision Biotech Co., Ltd
Phase 1/2 Unknown
NCT04271800 2023-04-18
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
Chongqing Precision Biotech Co., Ltd
Phase 1/2 Unknown
NCT05672420 2023-01-05
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
NCT05227898 2022-10-25
RESTORE
Blue Note Therapeutics
Phase NA Unknown
NCT04352556 2022-09-23
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
Unknown
NCT04764513 2022-03-28
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT05203809 2022-01-24
THERMAL
Malaghan Institute of Medical Research
Unknown
NCT04014894 2021-11-12
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Unknown
NCT04037189 2021-10-01
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Rabin Medical Center
Unknown
NCT00003337 2021-08-16
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 3 Unknown
NCT00003338 2021-08-16
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 2/3 Unknown
NCT04762485 2021-06-02
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 1/2 Unknown
NCT03262298 2021-02-09
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
Affiliated Hospital to Academy of Military Medical Sciences
Phase 1/2 Unknown
NCT02546739 2021-01-26
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Beijing Doing Biomedical Co., Ltd.
Phase 1 Unknown
NCT03271515 2021-01-20
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
Beijing Doing Biomedical Co., Ltd.
Phase 1 Unknown
NCT00498719 2020-12-31
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
M.D. Anderson Cancer Center
Unknown
NCT04610125 2020-10-30
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04497701 2020-08-04
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase NA Unknown
NCT04496011 2020-08-03
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation
Federal University of Health Science of Porto Alegre
Phase NA Unknown
NCT04406285 2020-05-28
Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.
Federal University of Health Science of Porto Alegre
Phase NA Unknown
NCT03977103 2020-01-13
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
University Of Perugia
Phase 2 Unknown
NCT04163575 2019-12-23
Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Kecellitics Biotech Company Ltd
Phase 1/2 Unknown
NCT03638206 2019-12-11
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT03836690 2019-10-25
ToTem
University College, London
Phase 1 Unknown
NCT04074213 2019-08-30
CLOZARIX
University Hospital, Caen
Unknown
NCT02349698 2019-06-25
A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
Southwest Hospital, China
Phase 1/2 Unknown
NCT02710149 2019-06-25
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies
Southwest Hospital, China
Phase 1/2 Unknown
NCT02935153 2019-06-25
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
Southwest Hospital, China
Phase 1/2 Unknown
NCT02954445 2019-06-25
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
Southwest Hospital, China
Phase 1/2 Unknown
NCT02958410 2019-06-25
A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies
Southwest Hospital, China
Phase 1/2 Unknown
NCT00503256 2019-05-09
Genetic Study of Chronic Lymphocytic Leukemia Families
M.D. Anderson Cancer Center
Unknown
NCT01240525 2019-02-12
ProT4
University College, London
Phase 2 Unknown
NCT03312205 2019-01-09
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
Phase 1/2 Unknown
NCT02537977 2018-12-03
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1/2 Unknown
NCT02933333 2018-10-17
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03556748 2018-06-14
WB-EMS and Nutrition in Patients With Hematological Malignancies
University of Erlangen-Nürnberg Medical School
Phase NA Unknown
NCT03373526 2017-12-18
Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation
Federal University of Juiz de Fora
Phase NA Unknown
NCT02822326 2017-09-11
Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia
Guangdong Provincial People's Hospital
Phase 1 Unknown
NCT02656147 2017-09-05
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
Beijing Doing Biomedical Co., Ltd.
Phase 1 Unknown
NCT01185886 2017-07-28
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Unknown
NCT03191773 2017-06-20
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2 Unknown
NCT03121625 2017-04-25
CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
Phase 1 Unknown
NCT02576327 2016-12-30
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02846584 2016-09-07
a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies
Southwest Hospital, China
Phase 2 Unknown
NCT02813837 2016-06-28
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Innovative Cellular Therapeutics Co., Ltd.
Phase NA Unknown